Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comparison of the Drug-Drug Interaction Potential of Daptomycin in Combination with Rifampin in Healthy Adult Volunteers.

Benefield RJ, Slechta ES, Gast CM, Spivak ES, Hanson KE, Alexander DP.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01525-18. doi: 10.1128/AAC.01525-18. Print 2018 Dec.

2.

Evaluation of the Vitek MS v3.0 Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Mycobacterium and Nocardia Species.

Body BA, Beard MA, Slechta ES, Hanson KE, Barker AP, Babady NE, McMillen T, Tang YW, Brown-Elliott BA, Iakhiaeva E, Vasireddy R, Vasireddy S, Smith T, Wallace RJ Jr, Turner S, Curtis L, Butler-Wu S, Rychert J.

J Clin Microbiol. 2018 May 25;56(6). pii: e00237-18. doi: 10.1128/JCM.00237-18. Print 2018 Jun.

3.

Helicobacter canis bacteraemia and cellulitis in a patient with end-stage renal disease.

Shakir SM, Powers-Fletcher MV, Slechta ES, Fisher MA.

JMM Case Rep. 2017 Nov 8;4(11):e005126. doi: 10.1099/jmmcr.0.005126. eCollection 2017 Nov.

4.

Multicenter Evaluation of the Vitek MS v3.0 System for the Identification of Filamentous Fungi.

Rychert J, Slechta ES, Barker AP, Miranda E, Babady NE, Tang YW, Gibas C, Wiederhold N, Sutton D, Hanson KE.

J Clin Microbiol. 2018 Jan 24;56(2). pii: e01353-17. doi: 10.1128/JCM.01353-17. Print 2018 Feb.

5.

Preclinical Assessment of a Fully Automated Multiplex PCR Panel for Detection of Central Nervous System Pathogens.

Hanson KE, Slechta ES, Killpack JA, Heyrend C, Lunt T, Daly JA, Hemmert AC, Blaschke AJ.

J Clin Microbiol. 2016 Mar;54(3):785-7. doi: 10.1128/JCM.02850-15. Epub 2015 Dec 30.

6.

Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.

Brown-Elliott BA, Hanson K, Vasireddy S, Iakhiaeva E, Nash KA, Vasireddy R, Parodi N, Smith T, Gee M, Strong A, Barker A, Cohen S, Muir H, Slechta ES, Wallace RJ Jr.

J Clin Microbiol. 2015 Mar;53(3):875-8. doi: 10.1128/JCM.02936-14. Epub 2015 Jan 7.

7.

Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory.

Barker AP, Horan JL, Slechta ES, Alexander BD, Hanson KE.

Med Mycol. 2014 Jul;52(5):537-45. doi: 10.1093/mmy/myu001. Epub 2014 Mar 30.

PMID:
24687961
8.

Rapid molecular detection of inducible macrolide resistance in Mycobacterium chelonae and M. abscessus strains: a replacement for 14-day susceptibility testing?

Hanson KE, Slechta ES, Muir H, Barker AP.

J Clin Microbiol. 2014 May;52(5):1705-7. doi: 10.1128/JCM.03464-13. Epub 2014 Feb 19.

9.

Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid.

Hansen J, Slechta ES, Gates-Hollingsworth MA, Neary B, Barker AP, Bauman S, Kozel TR, Hanson KE.

Clin Vaccine Immunol. 2013 Jan;20(1):52-5. doi: 10.1128/CVI.00536-12. Epub 2012 Oct 31.

10.

Isolation and identification of Kroppenstedtia eburnea isolates from multiple patient samples.

Barker AP, Simmon KE, Cohen S, Slechta ES, Fisher MA, Schlaberg R.

J Clin Microbiol. 2012 Oct;50(10):3391-4. doi: 10.1128/JCM.01186-12. Epub 2012 Aug 1. Erratum in: J Clin Microbiol. 2014 Oct;52(10):3831.

11.

Leptotrichia bacteremia in patients receiving high-dose chemotherapy.

Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE.

J Clin Microbiol. 2012 Apr;50(4):1228-32. doi: 10.1128/JCM.05926-11. Epub 2012 Jan 11.

12.

Internal transcribed spacer region sequence analysis using SmartGene IDNS software for the identification of unusual clinical yeast isolates.

Slechta ES, Hohmann SL, Simmon K, Hanson KE.

Med Mycol. 2012 Jul;50(5):458-66. doi: 10.3109/13693786.2011.630683. Epub 2011 Nov 22.

PMID:
22103344
13.

Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA.

Simmon KE, Brown-Elliott BA, Ridge PG, Durtschi JD, Mann LB, Slechta ES, Steigerwalt AG, Moser BD, Whitney AM, Brown JM, Voelkerding KV, McGowan KL, Reilly AF, Kirn TJ, Butler WR, Edelstein PH, Wallace RJ Jr, Petti CA.

Emerg Infect Dis. 2011 Sep;17(9):1692-700. doi: 10.3201/eid1709.101667.

14.

Roles of putative type II secretion and type IV pilus systems in the virulence of uropathogenic Escherichia coli.

Kulkarni R, Dhakal BK, Slechta ES, Kurtz Z, Mulvey MA, Thanassi DG.

PLoS One. 2009;4(3):e4752. doi: 10.1371/journal.pone.0004752. Epub 2009 Mar 9.

15.

Impact of the RNA chaperone Hfq on the fitness and virulence potential of uropathogenic Escherichia coli.

Kulesus RR, Diaz-Perez K, Slechta ES, Eto DS, Mulvey MA.

Infect Immun. 2008 Jul;76(7):3019-26. doi: 10.1128/IAI.00022-08. Epub 2008 May 5.

16.

Contact-dependent inhibition: bacterial brakes and secret handshakes.

Slechta ES, Mulvey MA.

Trends Microbiol. 2006 Feb;14(2):58-60. Epub 2006 Jan 4.

PMID:
16387500
17.

Adaptive mutation: general mutagenesis is not a programmed response to stress but results from rare coamplification of dinB with lac.

Slechta ES, Bunny KL, Kugelberg E, Kofoid E, Andersson DI, Roth JR.

Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12847-52. Epub 2003 Oct 14.

20.
21.

Amplification-mutagenesis: evidence that "directed" adaptive mutation and general hypermutability result from growth with a selected gene amplification.

Hendrickson H, Slechta ES, Bergthorsson U, Andersson DI, Roth JR.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2164-9. Epub 2002 Feb 5.

22.

Evidence that gene amplification underlies adaptive mutability of the bacterial lac operon.

Andersson DI, Slechta ES, Roth JR.

Science. 1998 Nov 6;282(5391):1133-5.

Supplemental Content

Loading ...
Support Center